The board of the investment company Curus has appointed Anna Dalgaard as chairman, succeeding business angel Lars Lindgren, who will continue as a board member. Curus recently took over the 2021 investment portfolio from Add Health Media, which has invested in digital health since 2016.
Today, there are 22 holdings in growth companies such as Mindler, Doctrin, Colivia, FindOut Diagnostic, Knodd, Health Integrator and others.
Anna Dalgaard was recruited to the board of Add Health Media in 2016 by Lars Lindgren and now she takes over the chairmanship of Curus.
– “I am very pleased that Anna wants to get even more involved in Curus in the future.
She has a long experience in digital healthcare and medtech at operational and strategic level as well as a broad network in the field and among investors, says Johan Bloom, CEO and founder of Curus.
Anna holds an MSc in Economics from the Stockholm School of Economics and has also studied medicine at Karolinska Institutet.
She has a background as a management consultant at McKinsey & Co and as a business developer in medical technology.
Anna co-founded the healthcare consulting company Health Navigator with the business idea of combining strategic and analytical skills with deep knowledge of healthcare and healthcare systems to offer consulting services, but also develop and realize new healthcare concepts.
In less than three years, the company grew to a turnover of over SEK 100 million and was very successful in creating unique ways to improve the care of multi-sick patients.
Today, she is Chairman of the Board of Hemcheck Sweden AB (publ) and FindOut Diagnostic AB and a board member of Ortivus AB (publ), ADDI Medical AB, Word Diagnostics AB and NRATIV AB.
– I am very much looking forward to our continued journey with Curus and building the future of healthcare through investments and acquisitions.
There are big shoes to fill after Lars Lindgren who has been very important for Curus, but I am happy that Lars continues to be involved in the company and on the board, adds Anna Dalgaard.
Curus’ Board of Directors currently consists of Anna Dalgaard (Chairman), business angel Lars Lindgren, Curus CEO Johan Bloom, Platform24 co-founder and medical specialist Tobias Perdahl and investor Ken Liebkind from Alfvén & Didrikson.
Several major investors, including Alfvén & Didrikson, Stefan Bengtsson, Christian Dahlberg and Alexander Stendahl, invested SEK 136 million in Curus to accelerate investments and acquisitions.
Curus recently completed an acquisition of Pharma Industry Publishing to strengthen Add Health Media’s role in media and education in health and medicine.  For more information: Johan Bloom, CEO Curus [email protected],+46 733 64 84 90 Anna Dalgaard, Chairman Curus [email protected],+46 73 410 01 13